Translation Translation regulation by Alpha-1 adrenergic receptors

No Pathway Network information available for Translation Translation regulation by Alpha-1 adrenergic receptors

Pathways in the Translation Translation regulation by Alpha-1 adrenergic receptors SuperPath

#	Name	Source	Genes
1	Translation Translation regulation by Alpha-1 adrenergic receptors	GeneGo (Thomson Reuters)	ADRA1A ADRA1B ADRA1D CALM1 CALM2 CALM3 CAMK2A CAMK2B CAMK2D CAMK2G EEF2 EEF2K EIF4A1 EIF4A2 EIF4E EIF4EBP1 EIF4G1 EIF4G3 GNA11 GNAO1 GNAQ GNB1 GNB2 GNB3 GNB4 GNB5 GNG10 GNG11 GNG12 GNG13 GNG2 GNG3 GNG4 GNG5 GNG7 GNG8 GNGT1 GNGT2 HRAS ITPR1 ITPR2 ITPR3 MAP2K1 MAP2K2 MAPK1 MTOR PIK3CB PIK3R1 PKN1 PLCB1 PLD1 PLD2 PRKCD PRKCE PTK2B RAF1 RHEB RHOA RPS6KB1 RPS6KB2 SHC1 SOS1 SRC TSC2 VAV2 (see all 65) (see less)
2	Development Activation of ERK by Alpha-1 adrenergic receptors	GeneGo (Thomson Reuters)	ADRA1A ADRA1B ADRA1D CACNA1C CALM1 CALM2 CALM3 CAMK2A CAMK2B CAMK2D CAMK2G FOS GNA11 GNA14 GNA15 GNAO1 GNAQ GNB1 GNB2 GNB3 GNB4 GNB5 GNG10 GNG11 GNG12 GNG13 GNG2 GNG3 GNG4 GNG5 GNG7 GNG8 GNGT1 GNGT2 HRAS ITPR1 ITPR2 ITPR3 JUN MAP2K1 MAP2K2 MAPK1 MAPK3 PIK3CB PIK3R1 PLCB1 PLCD1 PRKCA PRKCD PRKCE PTK2B RAF1 SHC1 SOS1 SRC TGM2 (see all 56) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	ADRA1D	Adrenoceptor Alpha 1D	Protein Coding	2
2	ADRA1B	Adrenoceptor Alpha 1B	Protein Coding	2
3	ADRA1A	Adrenoceptor Alpha 1A	Protein Coding	2
4	CALM1	Calmodulin 1	Protein Coding	2
5	CALM2	Calmodulin 2	Protein Coding	2
6	CALM3	Calmodulin 3	Protein Coding	2
7	CAMK2A	Calcium/Calmodulin Dependent Protein Kinase II Alpha	Protein Coding	2
8	CAMK2B	Calcium/Calmodulin Dependent Protein Kinase II Beta	Protein Coding	2
9	CAMK2D	Calcium/Calmodulin Dependent Protein Kinase II Delta	Protein Coding	2
10	CAMK2G	Calcium/Calmodulin Dependent Protein Kinase II Gamma	Protein Coding	2
11	PTK2B	Protein Tyrosine Kinase 2 Beta	Protein Coding	2
12	GNA11	G Protein Subunit Alpha 11	Protein Coding	2
13	GNAO1	G Protein Subunit Alpha O1	Protein Coding	2
14	GNAQ	G Protein Subunit Alpha Q	Protein Coding	2
15	GNB1	G Protein Subunit Beta 1	Protein Coding	2
16	GNB2	G Protein Subunit Beta 2	Protein Coding	2
17	GNB3	G Protein Subunit Beta 3	Protein Coding	2
18	GNG3	G Protein Subunit Gamma 3	Protein Coding	2
19	GNG4	G Protein Subunit Gamma 4	Protein Coding	2
20	GNG5	G Protein Subunit Gamma 5	Protein Coding	2
21	GNG7	G Protein Subunit Gamma 7	Protein Coding	2
22	GNG10	G Protein Subunit Gamma 10	Protein Coding	2
23	GNG11	G Protein Subunit Gamma 11	Protein Coding	2
24	GNGT1	G Protein Subunit Gamma Transducin 1	Protein Coding	2
25	GNGT2	G Protein Subunit Gamma Transducin 2	Protein Coding	2
26	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	2
27	ITPR1	Inositol 1,4,5-Trisphosphate Receptor Type 1	Protein Coding	2
28	ITPR2	Inositol 1,4,5-Trisphosphate Receptor Type 2	Protein Coding	2
29	ITPR3	Inositol 1,4,5-Trisphosphate Receptor Type 3	Protein Coding	2
30	PIK3CB	Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Beta	Protein Coding	2
31	PIK3R1	Phosphoinositide-3-Kinase Regulatory Subunit 1	Protein Coding	2
32	PRKCD	Protein Kinase C Delta	Protein Coding	2
33	PRKCE	Protein Kinase C Epsilon	Protein Coding	2
34	MAPK1	Mitogen-Activated Protein Kinase 1	Protein Coding	2
35	MAP2K1	Mitogen-Activated Protein Kinase Kinase 1	Protein Coding	2
36	MAP2K2	Mitogen-Activated Protein Kinase Kinase 2	Protein Coding	2
37	RAF1	Raf-1 Proto-Oncogene, Serine/Threonine Kinase	Protein Coding	2
38	SHC1	SHC Adaptor Protein 1	Protein Coding	2
39	SOS1	SOS Ras/Rac Guanine Nucleotide Exchange Factor 1	Protein Coding	2
40	SRC	SRC Proto-Oncogene, Non-Receptor Tyrosine Kinase	Protein Coding	2
41	GNB5	G Protein Subunit Beta 5	Protein Coding	2
42	PLCB1	Phospholipase C Beta 1	Protein Coding	2
43	GNG13	G Protein Subunit Gamma 13	Protein Coding	2
44	GNG2	G Protein Subunit Gamma 2	Protein Coding	2
45	GNG12	G Protein Subunit Gamma 12	Protein Coding	2
46	GNB4	G Protein Subunit Beta 4	Protein Coding	2
47	GNG8	G Protein Subunit Gamma 8	Protein Coding	2
48	RHOA	Ras Homolog Family Member A	Protein Coding	1
49	EEF2	Eukaryotic Translation Elongation Factor 2	Protein Coding	1
50	EIF4A1	Eukaryotic Translation Initiation Factor 4A1	Protein Coding	1
51	EIF4A2	Eukaryotic Translation Initiation Factor 4A2	Protein Coding	1
52	EIF4E	Eukaryotic Translation Initiation Factor 4E	Protein Coding	1
53	EIF4EBP1	Eukaryotic Translation Initiation Factor 4E Binding Protein 1	Protein Coding	1
54	EIF4G1	Eukaryotic Translation Initiation Factor 4 Gamma 1	Protein Coding	1
55	MTOR	Mechanistic Target Of Rapamycin Kinase	Protein Coding	1
56	PLD1	Phospholipase D1	Protein Coding	1
57	PLD2	Phospholipase D2	Protein Coding	1
58	PKN1	Protein Kinase N1	Protein Coding	1
59	RHEB	Ras Homolog, MTORC1 Binding	Protein Coding	1
60	RPS6KB1	Ribosomal Protein S6 Kinase B1	Protein Coding	1
61	RPS6KB2	Ribosomal Protein S6 Kinase B2	Protein Coding	1
62	TSC2	TSC Complex Subunit 2	Protein Coding	1
63	VAV2	Vav Guanine Nucleotide Exchange Factor 2	Protein Coding	1
64	EIF4G3	Eukaryotic Translation Initiation Factor 4 Gamma 3	Protein Coding	1
65	EEF2K	Eukaryotic Elongation Factor 2 Kinase	Protein Coding	1
66	CACNA1C	Calcium Voltage-Gated Channel Subunit Alpha1 C	Protein Coding	1
67	FOS	Fos Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
68	GNA15	G Protein Subunit Alpha 15	Protein Coding	1
69	JUN	Jun Proto-Oncogene, AP-1 Transcription Factor Subunit	Protein Coding	1
70	PLCD1	Phospholipase C Delta 1	Protein Coding	1
71	PRKCA	Protein Kinase C Alpha	Protein Coding	1
72	MAPK3	Mitogen-Activated Protein Kinase 3	Protein Coding	1
73	TGM2	Transglutaminase 2	Protein Coding	1
74	GNA14	G Protein Subunit Alpha 14	Protein Coding	1

Disorders associated with Translation Translation regulation by Alpha-1 adrenergic receptors SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Noonan syndrome and noonan-related syndrome	Enrichment	HRAS, MAP2K1, MAP2K2, RAF1, SOS1	8.53
2	Noonan syndrome 1	Enrichment	HRAS, MAP2K1, MAP2K2, RAF1, SOS1	7.50
3	Rasopathy	Enrichment	HRAS, MAP2K1, MAP2K2, RAF1, SOS1	7.21
4	Anastomosing haemangioma	Enrichment	GNA11, GNA14, GNAQ	7.18
5	Long qt syndrome 1	Enrichment	CACNA1C, CALM1, CALM2, CALM3, ITPR3	6.88
6	Focal cortical dysplasia, type ii	Enrichment	MTOR, RHEB, TSC2	6.38
7	Isolated focal cortical dysplasia type ii	Enrichment	MTOR, RHEB, TSC2	6.38
8	Noonan syndrome 3	Enrichment	HRAS, RAF1, SOS1	5.64
9	Catecholaminergic polymorphic ventricular tachycardia	Enrichment	CALM1, CALM2, CALM3	5.43
10	Phakomatosis cesioflammea	Enrichment	GNA11, GNAQ	4.78
11	Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi	Enrichment	GNA11, PIK3R1	4.30
12	Cardiofaciocutaneous syndrome 1	Enrichment	MAP2K1, MAP2K2	4.00
13	Cardiofaciocutaneous syndrome	Enrichment	MAP2K1, MAP2K2	4.00
14	Capillary malformations, congenital	Enrichment	GNA11, GNAQ	3.78
15	Hemimegalencephaly	Enrichment	MTOR, RHEB	3.65
16	Melanoma, uveal	Enrichment	GNA11, GNAQ	3.60
17	Long qt syndrome	Enrichment	CACNA1C, CALM1, CALM2	3.56
18	Melanocytic nevus syndrome, congenital	Enrichment	HRAS, RAF1	3.34
19	Overgrowth syndrome	Enrichment	MTOR, PIK3R1	3.33
20	Arteriovenous malformation	Enrichment	HRAS, MAP2K1	3.23
21	Myopathy, x-linked, with excessive autophagy	Enrichment	HRAS, MAP2K1	3.13
22	Lung non-small cell carcinoma	Enrichment	HRAS, MAP2K1	3.05
23	Autosomal dominant non-syndromic intellectual disability	Enrichment	CAMK2A, CAMK2B, GNB1	2.94
24	West syndrome	Enrichment	GNAO1, PLCB1, TSC2	2.92
25	Microcephaly	Enrichment	CAMK2B, GNAO1, GNB1, MAPK1	2.78
26	Congenital nervous system abnormality	Enrichment	CAMK2B, GNAO1, GNB5, TSC2	2.78
27	Nervous system disease	Enrichment	CAMK2B, GNAO1, GNB5, TSC2	2.78
28	Rare genetic intellectual disability	Enrichment	GNAO1, MTOR	2.64
29	Breast cancer	Enrichment	GNG3, JUN, SHC1	2.44
30	Anhidrosis, isolated, with normal sweat glands	Enrichment	ITPR2	2.38
31	Hypocalciuric hypercalcemia, familial, type ii	Enrichment	GNA11	2.38
32	Noonan syndrome 5	Enrichment	RAF1	2.38
33	Noonan syndrome 4	Enrichment	SOS1	2.38
34	Melorheostosis, isolated	Enrichment	MAP2K1	2.38
35	Nail disorder, nonsyndromic congenital, 3	Enrichment	PLCD1	2.38
36	Cardiomyopathy, dilated, 1nn	Enrichment	RAF1	2.38
37	Cardiofaciocutaneous syndrome 3	Enrichment	MAP2K1	2.38
38	Neurodevelopmental disorder with involuntary movements	Enrichment	GNAO1	2.38
39	Autoimmune lymphoproliferative syndrome, type iii	Enrichment	PRKCD	2.38
40	Sturge-weber syndrome	Enrichment	GNAQ	2.38
41	Neurodevelopmental disorder with hypotonia and dysmorphic facies	Enrichment	GNB2	2.38
42	Noonan syndrome 13	Enrichment	MAPK1	2.38
43	Charcot-marie-tooth disease, demyelinating, type 1j	Enrichment	ITPR3	2.38
44	Intellectual developmental disorder, autosomal recessive 63	Enrichment	CAMK2A	2.38
45	Intellectual developmental disorder, autosomal dominant 54	Enrichment	CAMK2B	2.38
46	Short syndrome	Enrichment	PIK3R1	2.38
47	Developmental and epileptic encephalopathy 17	Enrichment	GNAO1	2.38
48	Lodder-merla syndrome, type 2, with developmental delay and with or without cardiac arrhythmia	Enrichment	GNB5	2.38
49	Brugada syndrome 3	Enrichment	CACNA1C	2.38
50	Melorheostosis	Enrichment	MAP2K1	2.38
51	Leopard syndrome 2	Enrichment	RAF1	2.38
52	Immunodeficiency 36 with lymphoproliferation	Enrichment	PIK3R1	2.38
53	Cardiofaciocutaneous syndrome 4	Enrichment	MAP2K2	2.38
54	Long qt syndrome 16	Enrichment	CALM3	2.38
55	Hypocalcemia, autosomal dominant 2	Enrichment	GNA11	2.38
56	Charcot-marie-tooth disease, dominant intermediate f	Enrichment	GNB4	2.38
57	Agammaglobulinemia 7, autosomal recessive	Enrichment	PIK3R1	2.38
58	Thrombocytopenia 6	Enrichment	SRC	2.38
59	Intellectual developmental disorder, autosomal dominant 42	Enrichment	GNB1	2.38
60	Sick sinus syndrome 4	Enrichment	GNB2	2.38
61	Intellectual developmental disorder, autosomal dominant 53	Enrichment	CAMK2A	2.38
62	Trigonitis	Enrichment	RAF1	2.38
63	Intellectual developmental disorder, autosomal dominant 59	Enrichment	CAMK2G	2.38
64	Long qt syndrome 15	Enrichment	CALM2	2.38
65	Immunodeficiency 133 with ectodermal dysplasia with or without peripheral neuropathy	Enrichment	ITPR3	2.38
66	Atypical timothy syndrome	Enrichment	CACNA1C	2.38
67	Timothy syndrome type 2	Enrichment	CACNA1C	2.38
68	Gnao1-related disorder	Enrichment	GNAO1	2.38
69	Phakomatosis pigmentokeratotica	Enrichment	HRAS	2.38
70	Phakomatosis cesiomarmorata	Enrichment	GNA11	2.38
71	Kaposiform hemangioendothelioma	Enrichment	GNA14	2.38
72	Timothy syndrome type 1	Enrichment	CACNA1C	2.38
73	Cacna1c-related disorders	Enrichment	CACNA1C	2.38
74	Cardiomyopathy, familial hypertrophic, 1	Enrichment	CACNA1C, RAF1	2.36
75	Cardiac valvular dysplasia 1	Enrichment	PLD1	2.32
76	Parkinson disease 18, autosomal dominant	Enrichment	EIF4G1	2.32
77	Autism 19	Enrichment	EIF4E	2.32
78	Spinocerebellar ataxia 26	Enrichment	EEF2	2.32
79	Neurodevelopmental disorder with hypotonia and speech delay, with or without seizures	Enrichment	EIF4A2	2.32
80	Ectodermal dysplasia with facial dysmorphism and acral, ocular, and brain anomalies	Enrichment	RHOA	2.32
81	Linear hypopigmentation and craniofacial asymmetry with acral, ocular and brain anomalies	Enrichment	RHOA	2.32
82	Spinocerebellar ataxia 29	Enrichment	ITPR1	2.08
83	Fibromatosis, gingival, 1	Enrichment	SOS1	2.08
84	Costello syndrome	Enrichment	HRAS	2.08
85	Cutis marmorata telangiectatica congenita	Enrichment	GNA11	2.08
86	Timothy syndrome	Enrichment	CACNA1C	2.08
87	Pulmonic stenosis	Enrichment	SOS1	2.08
88	Ventricular tachycardia, catecholaminergic polymorphic, 4	Enrichment	CALM1	2.08
89	Angioma, tufted	Enrichment	GNA14	2.08
90	Night blindness, congenital stationary, type 1h	Enrichment	GNB3	2.08
91	Long qt syndrome 14	Enrichment	CALM1	2.08
92	Long qt syndrome 8	Enrichment	CACNA1C	2.08
93	Autosomal dominant hypocalcemia	Enrichment	GNA11	2.08
94	Lodder-merla syndrome, type 1, with impaired intellectual development and cardiac arrhythmia	Enrichment	GNB5	2.08
95	Tafro syndrome	Enrichment	MAP2K2	2.08
96	Cerebral visual impairment	Enrichment	GNB1	2.08
97	Wooly hair nevus	Enrichment	HRAS	2.08
98	Dystonia	Enrichment	CAMK2B, GNB1	2.04
99	Lymphangioleiomyomatosis	Enrichment	TSC2	2.02
100	Cebalid syndrome	Enrichment	MTOR	2.02
101	Smith-kingsmore syndrome	Enrichment	MTOR	2.02
102	Cerebral palsy	Enrichment	CACNA1C, GNB1	1.95
103	Gillespie syndrome	Enrichment	ITPR1	1.91
104	Nuchal bleb, familial	Enrichment	SOS1	1.91
105	Langerhans cell histiocytosis	Enrichment	MAP2K1	1.91
106	Immunodeficiency 14a with lymphoproliferation, autosomal dominant	Enrichment	PIK3R1	1.91
107	Neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures	Enrichment	CACNA1C	1.91
108	Large congenital melanocytic nevus	Enrichment	HRAS	1.91
109	Immunodeficiency 14	Enrichment	PIK3R1	1.91
110	Spermatocytoma	Enrichment	HRAS	1.91
111	Tuberous sclerosis 1	Enrichment	TSC2	1.84
112	Polycystic kidney disease, infantile severe, with tuberous sclerosis	Enrichment	TSC2	1.84
113	Heparin cofactor ii deficiency	Enrichment	EIF4G3	1.84
114	Tuberous sclerosis 2	Enrichment	TSC2	1.84
115	Hamartoma	Enrichment	TSC2	1.84
116	Xanthinuria, type ii	Enrichment	TSC2	1.84
117	Autism spectrum disorder	Enrichment	GNB1, MAP2K1, TSC2	1.81
118	Schimmelpenning-feuerstein-mims syndrome	Enrichment	HRAS	1.78
119	Spastic paraplegia 17, autosomal dominant	Enrichment	GNG3	1.78
120	Neurofibromatosis-noonan syndrome	Enrichment	MAP2K2	1.78
121	Lipodystrophy, congenital generalized, type 2	Enrichment	GNG3	1.78
122	Ventricular fibrillation, paroxysmal familial, 1	Enrichment	CACNA1C	1.78
123	Chromosome 22q11.2 deletion syndrome, distal	Enrichment	MAPK1	1.78
124	Spinocerebellar ataxia 15	Enrichment	ITPR1	1.78
125	Developmental and epileptic encephalopathy 12	Enrichment	PLCB1	1.78
126	Congenital generalized lipodystrophy	Enrichment	FOS	1.78
127	Noonan syndrome with multiple lentigines	Enrichment	RAF1	1.78
128	Epidermolytic nevus	Enrichment	HRAS	1.78
129	Gingival fibromatosis	Enrichment	SOS1	1.78
130	Familial sick sinus syndrome	Enrichment	GNB2	1.78
131	Tuberous sclerosis	Enrichment	TSC2	1.72
132	Heart conduction disease	Enrichment	CACNA1C	1.69
133	Histiocytoid hemangioma	Enrichment	FOS	1.69
134	Klippel-trenaunay-weber syndrome	Enrichment	GNAQ	1.61
135	Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy	Enrichment	CALM1	1.61
136	Spinocerebellar ataxia, autosomal recessive 16	Enrichment	ITPR1	1.61
137	Hemihyperplasia, isolated	Enrichment	RHOA	1.55
138	Nevus, epidermal	Enrichment	HRAS	1.54
139	Thyroid cancer, nonmedullary, 2	Enrichment	HRAS	1.54
140	Myelofibrosis	Enrichment	SRC	1.54
141	Capillary malformation-arteriovenous malformation 1	Enrichment	MAP2K1	1.54
142	Pilomyxoid astrocytoma	Enrichment	RAF1	1.54
143	Follicular thyroid carcinoma	Enrichment	HRAS	1.54
144	Catecholaminergic polymorphic ventricular tachycardia 1	Enrichment	CALM1	1.49
145	Hypothyroidism	Enrichment	GNB1	1.49
146	Choreatic disease	Enrichment	GNAO1	1.49
147	Polycystic kidney disease 1 with or without polycystic liver disease	Enrichment	TSC2	1.48
148	Renal cell carcinoma, papillary, 1	Enrichment	MTOR	1.48
149	Polycystic kidney disease 1	Enrichment	TSC2	1.48
150	Developmental and epileptic encephalopathy 14	Enrichment	PLCB1	1.44
151	Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies	Enrichment	CACNA1C	1.44
152	Autosomal non-syndromic agammaglobulinemia	Enrichment	PIK3R1	1.39
153	Adult hepatocellular carcinoma	Enrichment	TSC2	1.37
154	Leukemia, acute lymphoblastic	Enrichment	GNB1	1.35
155	Myelodysplastic syndrome	Enrichment	GNB1	1.35
156	Movement disease	Enrichment	GNAO1	1.35
157	Specific learning disability	Enrichment	MAPK1	1.35
158	Cardiac conduction defect	Enrichment	CACNA1C	1.31
159	Lip and oral cavity carcinoma	Enrichment	HRAS	1.31
160	Congenital long qt syndrome	Enrichment	ITPR3	1.31
161	Colorectal cancer	Enrichment	PIK3R1, SRC	1.30
162	Aortic valve disease 1	Enrichment	SOS1	1.28
163	Nk-cell enteropathy	Enrichment	PIK3CB	1.28
164	Multiple sclerosis	Enrichment	ITPR1	1.25
165	Osteoporosis	Enrichment	SRC	1.25
166	46,xy partial gonadal dysgenesis	Enrichment	SOS1	1.25
167	Anterior segment dysgenesis	Enrichment	ITPR1	1.22
168	Rhabdomyosarcoma	Enrichment	HRAS	1.19
169	Hypertension, essential	Enrichment	GNB3	1.17
170	Cleft palate, isolated	Enrichment	GNB1	1.17
171	Sudden infant death syndrome	Enrichment	CALM2	1.17
172	Renal cell carcinoma, nonpapillary	Enrichment	MTOR	1.16
173	Autosomal dominant polycystic kidney disease	Enrichment	TSC2	1.16
174	Heart, malformation of	Enrichment	MAPK1	1.14
175	Early infantile developmental and epileptic encephalopathy	Enrichment	GNAO1	1.14
176	Attention deficit-hyperactivity disorder	Enrichment	GNB5	1.06
177	Congenital stationary night blindness	Enrichment	GNB3	1.04
178	Complex neurodevelopmental disorder	Enrichment	CACNA1C, GNB2	1.03
179	Developmental and epileptic encephalopathy 1	Enrichment	GNAO1	1.01
180	Hydrops fetalis, nonimmune	Enrichment	HRAS	0.99
181	Brugada syndrome	Enrichment	CACNA1C	0.99
182	Strabismus	Enrichment	GNB1	0.98
183	Parkinson disease, late-onset	Enrichment	EIF4G1	0.96
184	Bladder cancer	Enrichment	HRAS	0.95
185	Differentiated thyroid carcinoma	Enrichment	HRAS	0.95
186	Non-immune hydrops fetalis	Enrichment	HRAS	0.92
187	Familial hypertrophic cardiomyopathy	Enrichment	RAF1	0.89
188	Left ventricular noncompaction	Enrichment	RAF1	0.87
189	Developmental and epileptic encephalopathy	Enrichment	GNAO1	0.86
190	Benign epilepsy with centrotemporal spikes	Enrichment	PLCB1	0.81
191	Centralopathic epilepsy	Enrichment	PLCB1	0.79
192	Thrombocytopenia	Enrichment	SRC	0.74
193	Spastic ataxia	Enrichment	ITPR1	0.71
194	Familial isolated dilated cardiomyopathy	Enrichment	RAF1	0.71
195	Autism	Enrichment	CAMK2G	0.59
196	Dilated cardiomyopathy	Enrichment	RAF1	0.55
197	Ovarian cancer	Enrichment	TSC2	0.41
198	Inherited cancer-predisposing syndrome	Enrichment	TSC2	0.33

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Translation Translation regulation by Alpha-1 adrenergic receptors

Pathway Network for Translation Translation regulation by Alpha-1 adrenergic receptors

Member Pathways for Translation Translation regulation by Alpha-1 adrenergic receptors

Pathways in the Translation Translation regulation by Alpha-1 adrenergic receptors SuperPath

Associated Genes for Translation Translation regulation by Alpha-1 adrenergic receptors

Associated Disorders for Translation Translation regulation by Alpha-1 adrenergic receptors

Disorders associated with Translation Translation regulation by Alpha-1 adrenergic receptors SuperPath

STRING Interaction Network for Translation Translation regulation by Alpha-1 adrenergic receptors

Sources for Translation Translation regulation by Alpha-1 adrenergic receptors